Metabolism resistant isothiazolone inhibitors of cartilage breakdown
| Autor: | Stephen W. Wright, Douglas Guy Batt, M. A. Pratta, Joseph J. Petraitis, Ronald L. Magolda, E. C. Arner, Susan R. Sherk, John V. Giannaras, Donald Joseph-Phillip Pinto, Orwat Michael James, Ronald L. Corbett, Bruce Freimark, Jean M. Williams, Susan V. Di Meo, Herman F. Stampfli |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
Pyridines
Indomethacin Clinical Biochemistry Pharmaceutical Science Matrix metalloproteinase Organ culture Biochemistry Structure-Activity Relationship Naproxen Organ Culture Techniques Reductive metabolism Microsomes Drug Discovery Nasal septum medicine Animals Molecular Biology Nasal Septum Chemistry Cartilage Organic Chemistry Metalloendopeptidases Metabolism Thiazoles medicine.anatomical_structure Microsome Pyrazoles Molecular Medicine Cattle Matrix Metalloproteinase 3 Proteoglycans Oxidation-Reduction Interleukin-1 |
| Zdroj: | Bioorganic & Medicinal Chemistry. 3:227-234 |
| ISSN: | 0968-0896 |
| Popis: | A series of 2-(arylmethyl)pyridoisothiazolones is reported that inhibit the IL-1 β induced breakdown of bovine nasal septum cartilage in an organ culture assay. The synthesis and preliminary SAR of these compounds are described. These compounds represent a novel, non-peptide lead series approach to the mediation of the chronic cartilage breakdown associated with arthritic disease. These compounds are relatively resistant to reductive metabolism by liver microsomal preparations and appear to inhibit cartilage breakdown by interfering with the proteolytic activation of matrix metalloproteinases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect